Catalysts for Ipca Pharmaceuticals Inc
88 tracked
Mar 18, 2026
approval
METOPROLOL TARTRATE — FDA approval
Ipca Pharmaceuticals Inc
→
Mar 18, 2026
approval
METOPROLOL TARTRATE — FDA approval
Ipca Pharmaceuticals Inc
→
Mar 18, 2026
approval
METOPROLOL TARTRATE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 6, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 6, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 6, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 5, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 5, 2025
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 5, 2025
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 5, 2025
approval
WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Apr 15, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Apr 3, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Apr 3, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Apr 3, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 30, 2023
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Jun 6, 2022
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Mar 4, 2022
approval
WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Jul 8, 2021
approval
WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Apr 14, 2021
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Aug 4, 2020
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Nov 5, 2019
approval
WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Jun 13, 2018
approval
CONTRAVE (BUPROPION HYDROCHLORIDE) — FDA approval
Ipca Pharmaceuticals Inc
→
Aug 25, 2017
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→
Aug 25, 2017
approval
BUPROPION HYDROCHLORIDE — FDA approval
Ipca Pharmaceuticals Inc
→